xl-101

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug Namexl-101
Drug Alias NamePAS-SLMA
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXL-protein GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXL-protein GmbH
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A